Form 4: United Therapeutics Director Judy D. Olian Executes Stock Option and Sells Shares
SEC Form 4 Filing
Director Judy D. Olian exercised stock options and sold shares of United Therapeutics Corp (UTHR) on May 3, 2024.
Summary
- On May 3, 2024, Judy D. Olian, a director of United Therapeutics Corp (UTHR), exercised stock options to acquire 10,000 shares of common stock at a price of $175.43 per share.
- Simultaneously, Olian sold a total of 10,000 shares in multiple transactions at weighted average prices ranging from $256.644 to $260.7668.
- Following these transactions, Olian directly owns 7,305 shares of United Therapeutics common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reflects routine transactions by a company director. The exercise of options and subsequent sale of shares is a common practice.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders, like directors and officers, trade their company's stock; these filings provide transparency into insider transactions and can be monitored for insights into management's perspective on the company's value and future prospects.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 06/26/2016 | Date exercisable for stock options |
| 05/03/2024 | Date of transaction: stock option exercise and share sales |
| 05/06/2024 | Date of signature on the Form 4 filing |
| 06/26/2025 | Expiration date for stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.